David B. Volkin

David B. Volkin is the Ronald T. Borchardt Distinguished Professor of Pharmaceutical Chemistry at The University of Kansas. He co-founded the Vaccine Analytics and Formulation Center (VAFC), focused on translating vaccine and biotherapeutic candidates into clinical trials through global collaborations with academia, industries, and non-profits. Previously, he spent 20 years in industry, leading R&D teams at Merck and J&J that advanced over 30 candidates into clinical trials, including approved vaccines like Gardasil™ and RotaTeq™.

• Education: B.A. in Chemistry (UC San Diego), Ph.D. in Biochemical Engineering (MIT)

His research emphasizes formulation science, analytical methodologies, and regulatory strategies for vaccines and monoclonal antibodies. He has authored ~220 publications and holds 15 U.S. patents.

Scientific Awards:

• AAPS Research Achievement Award in Biotechnology (2015)

Advising/Grants: While no specific students are listed, his VAFC leadership and industry partnerships reflect extensive collaborative work. Grants and funding details are not explicitly stated.

Labs/Teams: Directs the Vaccine Analytics and Formulation Center (VAFC), a multidisciplinary hub advancing translational research in vaccines and biotherapeutics.